{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:27:09Z","timestamp":1788978429225,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.leukres.2009.08.012","type":"journal-article","created":{"date-parts":[[2009,9,17]],"date-time":"2009-09-17T09:08:04Z","timestamp":1253178484000},"page":"912-916","source":"Crossref","is-referenced-by-count":31,"title":["Interleukin-6 leads to interleukin-10 production in several human multiple myeloma cell lines. Does interleukin-10 enhance the proliferation of these cells?"],"prefix":"10.1016","volume":"34","author":[{"given":"Eva","family":"Kovacs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2009.08.012_bib1","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1002\/cncr.11072","article-title":"A review of the cytokine network in multiple myeloma diagnostic, prognostic, and therapeutic implications","volume":"97","author":"Lauta","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2009.08.012_bib2","first-page":"443","article-title":"Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma","volume":"11","author":"Urbanska-Rys","year":"2000","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.leukres.2009.08.012_bib3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.biopha.2003.08.024","article-title":"How does interleukin-6 affect the membrane expressions of interleukin-6 receptor and gp130 and the proliferation of the human myeloma cell line OPM-2?","volume":"57","author":"Kovacs","year":"2003","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.leukres.2009.08.012_bib4","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1100\/tsw.2006.178","article-title":"Multiple myeloma and B cell lymphoma. Investigation of IL-6, IL-6 receptor antagonist (IL-6RA) and gp130 antagonist (gp130A) using various parameters in an vitro model","volume":"6","author":"Kovacs","year":"2006","journal-title":"Scientific World J"},{"key":"10.1016\/j.leukres.2009.08.012_bib5","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/blood.V73.2.517.517","article-title":"Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6","volume":"73","author":"Klein","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.08.012_bib6","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1365-2141.2000.02413.x","article-title":"Expression and production of interleukin 10 in human myeloma cell lines","volume":"111","author":"Otsuki","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2009.08.012_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/10428199909083381","article-title":"Interleukin-10 and Gp130 cytokines in human multiple myeloma","volume":"34","author":"Klein","year":"1999","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.leukres.2009.08.012_bib8","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1080\/10428190290021579","article-title":"IL-10 in myeloma cells","volume":"43","author":"Otsuki","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2009.08.012_bib9","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1182\/blood.V85.9.2521.bloodjournal8592521","article-title":"Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells","volume":"85","author":"Lu","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.08.012_bib10","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1182\/blood.V85.12.3423.bloodjournal85123423","article-title":"Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma","volume":"85","author":"Masood","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.08.012_bib11","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1182\/blood.V94.8.2871","article-title":"Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells","volume":"94","author":"Jones","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.08.012_bib12","first-page":"5499","article-title":"Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors","volume":"56","author":"Voorzanger","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2009.08.012_bib13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cyto.2007.02.022","article-title":"Serum levels of interleukin-15 and interleukin-10 and their correlation with proliferating cell nuclear antigen in multiple myeloma","volume":"37","author":"Pappa","year":"2007","journal-title":"Cytokine"},{"key":"10.1016\/j.leukres.2009.08.012_bib14","first-page":"467","article-title":"The cytostatic and cytocid effect of Viscum album extract","volume":"56","author":"Kovacs","year":"2006","journal-title":"Drug Res"},{"key":"10.1016\/j.leukres.2009.08.012_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/stem.5530130204","article-title":"Immunotherapy of multiple myeloma","volume":"13","author":"Huang","year":"1995","journal-title":"Stem Cells"},{"key":"10.1016\/j.leukres.2009.08.012_bib16","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.cyto.2005.06.006","article-title":"Comparative activity of Sant 7 and anti-IL-6, IL-6 monoclonal antibodies in a murine model of B cell lymphoma","volume":"31","author":"Campo","year":"2005","journal-title":"Cytokine"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609004196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609004196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T16:24:59Z","timestamp":1710606299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212609004196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0145212609004196"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2009.08.012","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}